The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
What this study shows
Review of the PI3K-AKT-mTOR network at the interface of oncogenic signalling and metabolism.
At a glance
| Evidence type | R Review — secondary literature, not a new result Marked R because it is a review or synthesis of existing evidence rather than a new primary result; that is a different form of writing, not a weaker one. |
| Study type | Narrative Review |
| Model system | Review |
| Journal | Nature reviews. Cancer |
| Year | 2019 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/s41568-019-0216-7 · PMID 31686003 · Free full text (PMC7314312) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Not applicable (review) |
| Target | PI3K-AKT (upstream of mTOR) |
| Model | Review |
| Effect | Reviews the PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism |
In the Atlas
Related topics
More studies on this topic
- The phosphoinositide 3-kinase pathway (2002)
- IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR Pathway (2026)
- A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation (2012)
- Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate (2011)
Was this page useful?
Thank you. Your answer was counted anonymously.